Our Latest News


October 5, 2021

Psyomics announces Stephanie Martlew as new CEO

Psyomics, a Cambridge University spin-out, developing technology to support earlier and improved mental health diagnosis and treatment management, has appointed a new CEO, effective 1st October 2021. Stephanie Martlew brings with her over 10 years of experience driving growth in creating scalable ways to improve mental health outcomes by using evidence-based digital technology. Psyomics announced […]

Read more

April 21, 2021

Question & Answer Interview with Sabine Bahn

Hi Sabine. We’re so excited to catch up with you. Thank you for taking the time to talk to us today, we know how busy you are. We’re now 4 months into the year. What are you most excited about from what Psyomics are working on this year? “It’s an incredibly exciting time for Psyomics. […]

Read more

March 31, 2021

Psyomics launches mental health assessment platform Censeo to market with two real world implementation projects

Psyomics, the innovative UK-based healthtech company, has launched its mental health assessment platform Censeo with two London based GP practices, to gather real-world data and feedback prior to commercial launch later this year. Built by psychiatrists, Censeo mirrors the rich process of a face-to-face psychiatric assessment, guiding a user through a series of adaptive questions. […]

Read more

March 30, 2021

Why are people with bipolar disorder waiting years for a diagnosis?

According to Bipolar UK, as many as 1 in 50 people have bipolar disorder, making it one of the most common long-term health conditions in the UK. For people living with bipolar, the condition touches every part of their lives, affecting their relationships, employment prospects and physical health, as well as increasing the risk of […]

Read more

March 24, 2021

Supporting mental health in the workplace, one year into the pandemic

It has now been one year since the initial restrictions to slow the spread of COVID-19 were imposed. According to a study by Mind in 2018, up to 40% of GP appointments are related to mental health. Covid has resulted in more people experiencing mental health concerns as well as worsening symptoms. The effect of […]

Read more

March 10, 2021

What’s the next frontier of technology in mental health?

By Professor Sabine Bahn, Co-Founder and Chief Medical Officer of Psyomics Technology was always going to impact the next phase of evolution within the health sector. But now that new technologies are available, what is next in the mental health space? According to MHFA England, 70-75% of people with diagnosable mental illness receive no treatment […]

Read more

November 11, 2020

Psyomics secures £1.5m funding to transform mental health diagnosis in the UK

Psyomics Ltd, a UK-based healthtech and University of Cambridge spin-out, has closed a £1.5 million funding round from existing and new investors to bring its mental health assessment and diagnosis platform, Censeo, to market in the UK. University spinout specialists Parkwalk led the round, joined by fellow existing investors Jonathan Milner, Martlet, and Cambridge Enterprise. […]

Read more

November 9, 2020

Psyomics appoints Barnaby Perks as Non-executive Director

Psyomics is delighted to announce that the Board has appointed Barnaby Perks as a new non-executive director. Mr Perks will assume his position from April 2018. Mr Perks brings to Psyomics a decade’s worth of experience in commercial strategy as a biotech leader which will be invaluable in helping Psyomics’ new digital tools reach the […]

Read more

Cambridge research aims to improve accuracy of mental health diagnosis

New research into improving the diagnosis of bipolar disorder and depression could help improve the lives of millions of people. Psyomics has received funding from the largest EU Research and Innovation programme, Horizon 2020 in recognition of potential success. This funding will help support the scientific development of an online screening system and research into […]

Read more